People

Michael Hanley

Joined Alto as COO in May 2024. His CNS pharmaceutical leadership experience includes commercial and business roles at Aeglea, Horizon and Lundbeck, across psychiatry and neurological diseases. He holds Notre Dame and Northwestern Kellogg degrees.